Table 3 Subset analysis of the levels of Factor VIII, VWF:Ag and VWF:RCo in FFP, ultrafiltration units, and cryoprecipitate from each blood type of donors.
From: Hemostatic capability of ultrafiltrated fresh frozen plasma compared to cryoprecipitate
A type | B type | O type | AB type | |
|---|---|---|---|---|
FFP | ||||
VWF:RCo (IU/m) | 76.8 ± 15.9 | 104.4 ± 20.4 | 76.6 ± 25.4 | 116.4 ± 20.8* |
VWF:Ag (IU/unit) | 96.8 ± 24.3 | 131.4 ± 45.5 | 82.4 ± 18.5 | 144.6 ± 24.6* |
FVIII (%) | 96.6 ± 21.9 | 123.9 ± 26.5 | 82.8 ± 22.0 | 131.6 ± 37.7* |
Fibrinogen (mg/dL) | 217.6 ± 51.3 | 283.4 ± 99.8 | 309.0 ± 53.5 | 281.2 ± 43.8 |
EXTEM-MCF | 18.5 ± 3.4 | 21.2 ± 7.1 | 24.6 ± 3.6 | 19.6 ± 2.5 |
NATEM-MCF | 19.3 ± 2.2 | 23.0 ± 9.2 | 23.6 ± 3.8 | 22.0 ± 4.1 |
Ultrafiltration | ||||
VWF:RCo (IU/m) | 206.0 ± 72.8 | 234.6 ± 83.4 | 180.8 ± 24.0 | 296.8 ± 48.4* |
VWF:Ag (IU/unit) | 222.4 ± 77.0 | 310.2 ± 112,0 | 221.6 ± 44.1 | 348.4 ± 55.7 |
FVIII (%) | 278.4 ± 57.3 | 314.2 ± 70.5 | 251.8 ± 62.5 | 390.5 ± 62.9* |
Fibrinogen (mg/dL) | 634.0 ± 94.7 | 788.4 ± 131.5 | 799.0 ± 98.5 | 646.0 ± 177.8 |
EXTEM-MCF | 29.8 ± 2.9 | 38.6 ± 7.6 | 41.8 ± 9.2 | 34.4 ± 7.7 |
NATEM-MCF | 30.5 ± 3.1 | 36.0 ± 5.8 | 37.2 ± 5.4 | 33.0 ± 7.0 |
Cryoprecipitate | ||||
VWF:RCo (IU/m) | 619.4 ± 145.2 | 641.8 ± 81.1 | 458.4 ± 160.7 | 741.0 ± 208.1 |
VWF:Ag (IU/unit) | 874.8 ± 161.6 | 937.6 ± 289.8 | 609.0 ± 154.4 | 1040.8 ± 350.3 |
FVIII (%) | 492.4 ± 157.8 | 593.7 ± 259.4 | 356.8 ± 142.9 | 504.5 ± 100.0 |
Fibrinogen (mg/dL) | > 900 | > 900 | > 900 | > 900 |
EXTEM-MCF | 65.4 ± 4.7 | 65.6 ± 14.7 | 66.6 ± 7.7 | 62.4 ± 13.0 |
NATEM-MCF | 67.6 ± 7.3 | 65.8 ± 13.8 | 67.8 ± 9.7 | 65.6 ± 12.9 |
